Key statistics dashboard for Apyx Medical Corporation (APYX). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM).
Stock Data
| Price | $3.03 |
| Market Cap | $128M |
| Enterprise Value | $139.0M |
| Beta | 1.54 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -14.56 |
| Price / Book | 11.90 |
| P/S | 2.17 |
| EV/EBITDA | -84.90 |
| EV/Sales | 2.38 |
| EV/FCF | -12.58 |
| P/FCF | -11.47 |
| Earnings Yield | -6.79% |
| FCF Yield | -8.70% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 33.94% |
| EBIT Margin | -4.09% |
| EBITDA Margin | -2.80% |
| Operating Margin | -6.06% |
| Net Margin | -14.78% |
| Return on Equity | -78.70% |
| Return on Assets | -14.14% |
| Return on Invested Capital | -6.78% |
| Return on Capital Employed | -6.84% |
Financial Health
| Current Ratio | 5.68 |
| Quick Ratio | 4.53 |
| Cash Ratio | 2.95 |
| Debt / Equity | 3.72 |
| Debt / Assets | 64.89% |
| Net Debt / EBITDA | -7.34 |
| Interest Coverage | -0.63 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 1.15 |
Per-Share Data
| Revenue per share | 1.39 |
| Book Value per share | 0.26 |
| Cash per share | 0.66 |
| FCF per share | -0.26 |
| Tangible Book Value per share | 0.26 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 8 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 9 |
| Avg rating (1-5) | 0.89 |
Related companies: ATOS · LUCD · NSPR · PDEX · QIPT · RCEL · RPID
Explore sector: Healthcare · Medical - Specialties
More sections of APYX: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks